These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 3480051
1. Human-human hybridomas generated with lymphocytes from patients with colorectal cancer. Borup-Christensen P, Erb K, Jensenius JC, Svehag SE, Nielsen B. Cancer Detect Prev Suppl; 1987; 1():207-15. PubMed ID: 3480051 [Abstract] [Full Text] [Related]
2. Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients. Kjeldsen TB, Rasmussen BB, Rose C, Zeuthen J. Cancer Res; 1988 Jun 01; 48(11):3208-14. PubMed ID: 3365703 [Abstract] [Full Text] [Related]
3. Isolation and characterization of a human monoclonal antibody which reacts with breast and colorectal carcinoma. Goldstein NI, Nagle R, Villar H, Hersh E, Fisher PB. Anticancer Res; 1990 Jun 01; 10(6):1491-500. PubMed ID: 1704693 [Abstract] [Full Text] [Related]
6. Production of anti-tumor human monoclonal antibodies using different approaches. Liu H, Xu ZL, Wang Y, Yang L, Feng O, Li Y, Wang YM, Zhang GG. Hum Antibodies Hybridomas; 1993 Jan 01; 4(1):2-8. PubMed ID: 8381684 [Abstract] [Full Text] [Related]
7. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma. Martin RF, Kisor R, Schroer D, Eichler G, Filaccio ML. Hum Antibodies Hybridomas; 1990 Jan 01; 1(3):154-9. PubMed ID: 2103359 [Abstract] [Full Text] [Related]
12. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient. Abdel-wahab ZA, Gillanders WE, Darrow TL, Seigler HF. Hum Antibodies Hybridomas; 1992 Jan 01; 3(1):32-9. PubMed ID: 1576321 [Abstract] [Full Text] [Related]
13. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer. Cote RJ, Morrissey DM, Oettgen HF, Old LJ. Fed Proc; 1984 Jun 01; 43(9):2465-9. PubMed ID: 6327400 [Abstract] [Full Text] [Related]
15. A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines. Cole SP, Campling BG, Louwman IH, Kozbor D, Roder JC. Cancer Res; 1984 Jul 01; 44(7):2750-3. PubMed ID: 6327024 [Abstract] [Full Text] [Related]
16. Generation of a monoclonal antibody (G9) reactive with an organ-specific, tumor-associated epitope of human colon carcinoma. Gold DV, Ishizaki G, Keller P, Lew K. Cancer Res; 1989 Nov 15; 49(22):6412-8. PubMed ID: 2478283 [Abstract] [Full Text] [Related]
17. [Human monoclonal antibody constructed by lymphocytes from pancreatic cancer patients]. Tanaka H. Nihon Geka Gakkai Zasshi; 1989 Jan 15; 90(1):93-101. PubMed ID: 2539553 [Abstract] [Full Text] [Related]
18. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach. Tong AW, Lee J, Stone MJ. Cancer Res; 1984 Nov 15; 44(11):4987-92. PubMed ID: 6207911 [Abstract] [Full Text] [Related]
20. A human monoclonal antibody directed to blood group i antigen: heterohybridoma between human lymphocytes from regional lymph nodes of a lung cancer patient and mouse myeloma. Hirohashi S, Clausen H, Nudelman E, Inoue H, Shimosato Y, Hakomori S. J Immunol; 1986 Jun 01; 136(11):4163-8. PubMed ID: 2422274 [Abstract] [Full Text] [Related] Page: [Next] [New Search]